Posts by Sandra Ansanay-Alex
Swiss Biotech Sector Shows Strength and Growth in 2024
Despite a challenging global market environment, the Swiss biotech sector once again demonstrated strength and resilience in 2024, as detailed in the newly released 2025 Swiss Biotech Report presented on 5 May 2025 during the Swiss Biotech Days. Co-authored by the Swiss Biotech Association, EY, and eight partner organizations, the report offers a deep dive…
Read MoreOncoSwab Secures CHF 1.3 Million Innosuisse Grant to Advance Lung Cancer Early Detection
OncoSwab, a Jura-based startup pioneering non-invasive cancer diagnostics, has secured a CHF 1.3 million Innosuisse grant to fund upcoming clinical trials in partnership with Inselspital Bern. The grant will enable OncoSwab to accelerate the clinical validation of its nasal fluid-based biomarker test — a revolutionary approach to the early detection of lung cancer. Addressing…
Read MoreMedical devices: Switzerland soon aligned with the FDA?
The Swiss government is working on a simplified validation procedure for medical devices that have already been authorised by the US FDA – involving private bodies in the assessment. During a session on 30 April 2025, the Federal Council has laid the groundwork for a wider supply of medical devices. The aim is…
Read MoreBioAlps Forum @ ILMAC Lausanne 2026
Ilmac will take place from 23 to 24 September 2026 in Palais Beaulieu, Lausanne. BioAlps will organise the Forum on Day 2 and host biotools startups on its booth. Every two years, Ilmac Lausanne organises the largest meeting place for the chemical and life science industry in Western Switzerland. BioAlps, whose mission is to empower…
Read MoreAktiia closes a CHF 34 million Series B and becomes Hilo
Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by Earlybird Health and Wellington Partners, with new investors Kfund and naturalX Health Ventures, and participation from existing investors redalpine, Khosla Ventures, Molten Ventures, Translink Capital and Verve Ventures. The investment, which has brought the total financing to…
Read MoreGESICA: Strengthening Cross-Border Health Crises Readiness
In an era marked by mounting pressure on healthcare systems and a growing number of exceptional public health emergencies, cross-border scientific collaboration has never been more critical. The GESICA project—GEstion des SItuations de Crises sAnitaires—is designed to address this challenge by enhancing the ability to detect, anticipate, and manage health crises across the France–Switzerland region.…
Read MoreBioscibex, Inkocell Therapeutics, and OrthoSens Supported By Venture Kick
Bioscibex, Inkocell Therapeutics, and OrthoSens were selected at Venture Kick’s second financial and entrepreneurial support stage and get each a CHF 40’000 support. These three Swiss Health Valley startups reshape biopharma, oncology, and orthopedic recovery. Bioscibex, Inkocell Therapeutics, and OrthoSens have progressed to the second stage of Venture Kick, securing support to drive their innovations…
Read MoreAerospec, Carewell, OptiZone and SaisiR Finalists of the PERL Prize
Four Swiss Health Valley start-ups selected from the 5 finalists in the 23rd Prix Entreprendre Lausanne Région (PERL): Aerospec, Carewell, OptiZone and SaisiR. Nearly 60 companies from the Lausanne region applied for the PERL 2025 awards. Only five have been selected for the Awards Ceremony, to be held on Wednesday 7 May, and only one…
Read MoreHealium, Hikane and LittleCubes Supported By FIT
These three new life sciences projects have each been awarded a FIT Impact grant of 10,000 CHF. Healium is developing Medicase, a compact and connected pill-dispenser designed to improve adherence to treatment. Designed for the visually impaired, Hikane is a compact device that attaches to any white cane and provides haptic feedback to signal the…
Read MoreHeroSupport Partners With Swiss Medical Network
HeroSupport, a HUG spin-off founded in 2022 by medical physicist Giovanna Dipasquale, is redefining breast cancer treatment with its 3D-printed, custom-made shells designed to improve the precision and comfort of radiotherapy. The Geneva-based startup has just announced a strategic partnership with Swiss Medical Network, a major milestone in its mission to enhance cancer care. …
Read More